On the afternoon of January 4, the Shandong Provincial Medical Insurance Bureau issued the "Notice on Further Strengthening the Management of the Whole Process of Centralized Procurement of Drugs and Medical Consumables".It is clear that the whole process management of centralized procurement of drugs and medical consumables will be further strengthened. 
The document proposes to accelerate the monitoring of the whole process of centralized procurement of medical consumables in batches, and first launch the monitoring function of national coronary stentsBy the end of 2024, the monitoring function of centralized procurement of medical consumables in each batch will be fully applied. In terms of regulation, first targeted:One end of the medical institution
Continuously improve the monitoring and notification systemFrom the third month after the implementation of the results of each batch of centralized procurement, the local medical insurance departments should investigate and sort out the admission of the selected products in medical institutions, and supervise the relevant medical institutions to fulfill the agreement as soon as possible. In principle, a notification reminder will be carried out on a quarterly basis.
Ensure that the agreed purchase quantity of the selected products is completedThe proportion of unfinished purchases and non-selected products in the total use of the same variety of drug consumables is higher than 50%.Related breedsIt will be regarded as unqualified in the assessment.
Improve the management level of the selected products in the hospitalFor the large use of non-selected, alternative drugs and the implementation of the relevant medical consumables system (set) procurement policy, a large number of more than the selected price of the set,After receiving the notification, the medical institution should promptly transmit it to the medical personnelContinuously improve the management level of the hospital. ForPharmaceutical companies at one end, the document is clearSet different warning lines with a distribution rate of consumables with volume purchase less than %. If the following problems occur in the selected companywill be given a severe penalty of reducing the agreed purchase volume, prohibiting participation in centralized procurement, and being included in the blacklist of punishment for dishonesty!For the selected enterprises with a delivery rate of less than 80%.Alert the risk of reporting
For the selected enterprises with a delivery rate of less than 60%.Reduce the amount of agreed purchases
For the selected enterprises with a delivery rate of less than 30%.Not acceptedParticipate in centralized procurement
It can be said that under this mechanism, whether it is the procurement volume of medical institutions that is not up to standard, the illegal use of non-selection, or the relevant enterprises if the supply of selected products is not timely, the distribution rate is low, and the distribution is not in place, there will be nowhere to hide!In 2023, the monitoring and inspection of the whole process of medical consumables procurement has begun to be intensively implemented across the country!series
Haiming medical device series exhibition
Hebei Medical Equipment Exhibition
Exhibition time:
March 2-4, 2024.
Exhibition Venue:
Shijiazhuang International Convention and Exhibition Center (Zhengding New Hall).
Subject:
Innovative medical technology and health lead the future.
Exhibition scale:
15000 exhibition area.
500+ exhibitors.
30,000+ estimated visitors.
With its mature market operation mode and professional exhibition services, Hebei Medical Exhibition has gradually developed into one of the most influential industry events in northern China.
Qingdao Medical Equipment Exhibition
Exhibition time:
June 27-29, 2024.
Exhibition Venue:
Qingdao International Convention and Exhibition Center (No. 9, Miaoling Road, Laoshan District).
Subject:
Innovation, intelligence, integration and development.
Exhibition scale:
The exhibition area is 20000
There are 500+ exhibitors.
It is expected that the audience will be 30,000+ people.
10+ high-end forums.
This exhibition showcases the latest technology in the field of medical device city manufacturing and promotes the interaction and exchange of the entire industrial chain of medical devices. 【Haiming Medical Expo】